Drug Development Medical Schools Pharmaceutical Companies 
STAT
AUGUST 19, 2024
. The company — or, at least, what existed at its founding in 2013 — hoped to pull data from images of healthy and diseased cells, and use that data to identify drugs gathering dust on pharmaceutical company shelves that could be repurposed as rare disease treatments.
STAT
MARCH 7, 2023
BOSTON — FDA Commissioner Robert Califf said on Monday that it “bothers” him that Novo Nordisk, which makes an obesity medication, funded the development of obesity coursework for medical schools.
European Pharmaceutical Review
SEPTEMBER 2, 2022
She has worked with regulatory agencies and pharmaceutical companies for over 10 years. She also has been conducting fundamental research as an academic in several universities, with her last academic position held at Harvard Medical School. US Food and Drug Administration. About the author. Available from: [link].
Expert insights. Personalized for you.
362 
Let's personalize your content